Federal officials toured the FUJIFILM Diosynth Biotechnologies' Innovation Center, where employees are helping to fight COVID-19. | Stock Photo
Federal officials toured the FUJIFILM Diosynth Biotechnologies' Innovation Center, where employees are helping to fight COVID-19. | Stock Photo
State House Speaker Tim Moore (R-Cleveland) joined federal officials on their tour of the FUJIFILM Diosynth Biotechnologies' Innovation Center in Morrisville in July.
The facility is part of the federal effort to quickly create a COVID-19 vaccine.
Moore thanked the president for realizing the hard work that North Carolina and Americans are doing regarding scientific research about the coronavirus, he said in a July 27 statement about the federal visit and tour.
"President Trump recognizes that American ingenuity creates solutions to the world’s greatest challenges, and North Carolina is a global hub for scientific research thanks to a commitment to connecting our exceptional economic and education systems," Moore said in the statement.
The FUJIFILM Diosynth has 500 employees who are working on a potential vaccine for COVID-19. The potential vaccine is expected to enter phase two of clinical trials in August, the news release states.
The state has been producing drugs that have had some effect on the coronavirus treatment, including Remdesivir, which was developed through Gilead Sciences and the Baric Lab at the UNC Gillings School of Global Public Health, Moore said in the news release.
Alerts Sign-up